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Abstract 
Background: Neonates are highly vulnerable to drug toxicities because of 
their age-related limitations in drug metabolisms and renal excretion. Lack of 
the knowledge and/or education for medical professionals about the right dose 
administration and the lack of neonate-specific formulations are the additional 
dilemmas.  
Cases Presentation: Here, we reported six neonates presented with severe drug 
toxicities, including acetaminophen, digoxin, theophyllin, lidocaine and opium 
and they were successfully treated in NICU at Amirkola Children’s Hospital, 
Babol– in the north of Iran. Most of the toxicities were originated from the lack 
knowledge of physician or parents for selecting the right drug and dose of drug 
for newborn babies. 
Conclusions: Better education of medical professional and parents are needed 
to avoid neonatal drug toxicities.  
Keywords: Toxicity, Neonatal, Drug, Acetaminophen, Digoxin, Theophyllin, 
Lidocaine and Opium 
 
 
 
 
 
 
Introduction 
Neonates are at great risk to develop drug toxicities because of immaturity 
of their drug metabolism and disposal mechanism [1, 2]. These limitations 
determine the efficacy and/or safety of a therapeutic or inadvertent drug 
exposure [3, 4]. So a strict policy must be undertaken when a drug is 
administered in and outpatient clinic and also for neonates admitted to the 
hospital. Furthermore, the treatments of severe drug toxicity in neonatal period 
including peritoneal dialysis or hemodyalisis have several limitations in 
neonatal period in developing countries. Here, we reported six neonates 
presented with severe drug toxicities, including acetaminophen, digoxin, 
theophyllin, lidocaine and opium and they were successfully treated in NICU at 
Amirkola Children's Hospital, Babol– in the north of Iran. 
 
 
Cases Presentation 
Case 1: 
A term newborn was brought to the outpatient clinics of our hospital 
because of vomiting and bad general condition. He was visited 3 days ago and 
referred to a cardiologist because of a harsh systolic murmur, which was found 
on routine physical examination. Lanoxin elixir 50 µg/ml (GlaxoSmithKline 
company) with a dose of 0.2 mL BD was commenced by cardiologist for the 
diagnosis of large VSD, but because of misinterpretation by pharmacist he 
received 2 ml TDS (Instead of 0.2 ml BD) for 4 doses. He developed severe 
digoxin toxicity. He was admitted to NICU immediately and a two-volume 
blood exchange transfusion was done for two times. Plasma digoxin level has  
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not been measured, because of its unavailability. His 
general condition recovered and he was discharged with 
maintenance dose of digoxin and a good general 
condition. 
Case 2: 
A full term, well baby with moderate hyper-
bilirubinemia was visited by a pediatrician at 4th day of 
life and he was given erroneously Phenobarbital to treat 
hyperbilirubinemia. Theophyllin retard tab 250 mg was 
given to the baby instead of phenobarbital tab 15 mg by 
a pharmacist. He developed vomiting and severe 
convulsions. So he was admitted to NICU and 
mechanical ventilation started because of respiratory 
failure and exchange transfusions was done for two 
times. After recovery for 7 days, he was discharged 
with phenobarbital as a maintenance therapy for his 
seizure and abnormal brain CT scan. He is now alive 
without need for medication for seizure.  
Case 3: 
A well baby circumcised by a general surgeon at 7th 
day of life. He was given acetaminophen 325 mg adult 
suppository every 2 hours and was discharged to home. 
When he was brought to our hospital, he was taken 5 
suppositories of adult acetaminophen. He was admitted 
to NICU because of vomiting and decrease of neonatal 
reflexes and level of consciousness. Treatment with 
intravenous infusion of N-Acetylcystein began. Apnea 
and recurrent seizure occurred in first day of admission. 
Ultimately, he intonated and the respiratory support 
with ventilator started. Finally, he was discharged with 
Phenobarbital as a maintenance therapy for his seizure. 
He is now alive as a spastic cerebral palsy patient. 
Case 4: 
 A 28-day-old neonate was admitted to NICU 
because of seizure. He was circumcised by a general 
physician 2 hours ago. For local anesthesia and dorsal 
penile nerve block (DPNB) he received lidocaine 2% 
five milliliters, three times more than the usual dosage. 
Twenty minutes after injection of lidocaine, he 
developed convulsion and wrongly treated with rectal 
diazepam. Apnea after treatment with diazepam 
occurred. Apnea recovered with mouth-to-mouth 
ventilation and then patient was brought to our hospital. 
He was conservatively treated and discharged with a 
good general condition after recovery.  
Case 5 & 6: 
A full term and 20-day-old male neonate was 
admitted to NICU with apnea and cyanosis. On physical 
exam, his pupil was miotic and there were the decrease 
of neonatal reflexes and bradypnea. The detailed history 
revealed that his parents give him opium extract to 
relieve his crying and colic. The patient was treated 
with naloxone HCL and after recovery; he was 
discharged with a good condition.  
 In addition, a six-day-old neonate was visited in 
emergency room with drossiness, cyanosis and 
respiratory distress. Her parents gave opiate to her 
because of her restlessness. After admission to NICU 
and treatment with naloxone her respiratory condition 
and drossiness responded to therapy and the sign and 
symptom of opium toxicity was disappeared. 
 
 
Discussion 
In these case series of study, we reported several 
neonatal drug toxicities which were occurred because of 
high toxic dose administration and the most of drugs 
were prescribed by a physician, but two of them were 
given opium by their parents as home folk remedy. 
Drug therapy in neonate has not been totally safe 
and effective, even by a physician. The drug pharma-
cokinetic like absorption, distribution, metabolism and 
excretion in neonatal period differs significantly from 
other age groups. The knowledge about the right drug 
selection and the right dose administration together with 
the serum level monitoring is required [5] to improve the 
safety and avoid toxicity in neonatal period. Most of 
digoxin toxicities in neonates are due to wrong dose 
administration and/or renal failure, because it has a 
narrow margin of safety. Although the drug of choice 
for the treatment of digoxin toxicity is the digoxin-
specific Fab antibody fragment [6], but because of its 
unavailability, we have successfully treated our severely 
sick baby with blood exchange transfusion, although 
because of large extravascular volume of distribution, 
digoxin is not effectively removed by exchange 
transfusion [7]. 
Rectal acetaminophen toxicity in our cases 
highlights the need for better education of medical 
professionals including general surgeon regarding the 
appropriate use and dose of acetaminophen in 
newborns. In our case report, he received an adult 
acetaminophen suppository 325 mg every two hours up 
to five times (5×325=1625 mg), so the total dose is near 
11.6 times higher than the toxic dose. Acute intake of 
more than 140 mg/kg of acetaminophen establishes 
potential risk for acetaminophen toxicity and requires 
urgent evaluation [8]. He was vigorously treated with 
intravenous N-acetylcysteine (NAC) infusion protocol 
without any adverse effects, but he developed severe 
seizure and encephalopathy. A similar case of 
acetaminophen toxicity with encephalopathy and 
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oliguric renal failure was reported in a term neonate 
after circumcision in the United State of America [9]. 
Although the treatment of choice is NAC infusion, one 
case of acetaminophen toxicity reported by Lederman in 
an infant of 29 weeks' gestation who was exposed to the 
drug when his mother ingested 32.5 g, 16 hours before 
delivery and the infant was treated with exchange 
transfusions [10]. 
Circumcision is the most common surgical procedure 
performed in the neonatal period in our community. The 
most widely used pharmacological agent for pain 
management during circumcision is dorsal penile nerve 
block (DPNB) by injected lidocaine [11]. Maximum safe 
doses of lidocaine are 5 mg/kg without epinephrine. 
Concentrated preparation (e.g., 2%) should not be used 
because diluted solutions (0.3%) are equally effective as 
concentrated solution (1-2%). Diluted solutions also 
causes less burning discomfort on injection and permit 
use of larger volumes without achieving toxic doses. 
For example, a 5 kg infant for suturing may safely 
receive up to 5×5= 25 mg of lidocaine. This maximum 
dose would be given with either 1.25 mL of lidocaine 
2%, 2.5 mL of lidocaine 1%, or 5 mL of lidocaine 0.5% 
[12].  
The diagnosis of neonatal drug toxicities requires a 
high index of suspicion. One of the limitations in our 
cases was the lack of confirmation of the diagnosis by 
serum level determination because of its unavailability 
and the admission of the patient on holiday to the 
private laboratory which was closed and responsible to 
check the serum level. Although the net diagnosis 
required serum level determination, we could not 
postpone the immediate therapeutic measures in the 
presence of a reliable history of drug exposure and a 
wrong written dose on a prescription, accompanied with 
the typical clinical sign and symptoms, for most 
offending agent, qualitative measurement is not possible 
or likely to change the decision for treatment [13]. 
In conclusion, the better education of medical 
professional and parents are required to avoid neonatal 
drug toxicities. 
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